Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
February-2025 Volume 29 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2025 Volume 29 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Network pharmacology‑based analysis and in vitro experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway

  • Authors:
    • Xin-Xing Lin
    • Pei-Qing Yang
    • Xiao-Jun Li
    • Zhong-Zhen Xu
    • Hai-Tao Wu
    • Shun-Ming Hu
    • Xiao-Lei Yang
    • Yong Ding
    • Wei-Zhou Yu
  • View Affiliations

    Affiliations: Department of General Surgery, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China, Department of Gastroenterology, Dafeng People's Hospital, Yancheng, Jiangsu 224100, P.R. China
  • Published online on: November 26, 2024     https://doi.org/10.3892/ol.2024.14822
  • Article Number: 76
  • Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the inhibitory effect of luteoloside on the proliferation, migration and invasion of gastric cancer (GC) cells based on network pharmacology and in vitro experiments. GC‑associated targets were obtained from the GeneCards and Online Mendelian Inheritance in Man databases. Gene Ontology functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integrated Discovery. Protein‑protein interaction (PPI) networks and herb‑active ingredient‑target gene‑signaling pathway networks were constructed using the Search Tool for the Retrieval of Interacting Genes and proteins and Cytoscape software to analyze core target genes and pathways. In addition, the alkaline comet assay was performed to assess DNA damage, demonstrating that luteoloside induces DNA double‑strand breaks in a concentration‑dependent manner, as indicated by increased comet tail lengths. γ‑H2AX detection through western blot analysis further corroborated these findings, showing significant upregulation of this DNA damage marker in luteoloside‑treated GC cells. The human GC cell line NCI‑N87 was utilized for in vitro experiments to investigate the impact of different doses of luteoloside on cell proliferation, invasion and migration using Cell Counting Kit‑8, scratch‑wound and Transwell assays, respectively. The underlying molecular mechanism of luteoloside was explored using western blot analysis. The successfully constructed PPI network revealed the p53, Akt1, Bcl‑2 and Caspase‑3 proteins as the core targets, all of which showed good binding activity with luteoloside. The in vitro experiments demonstrated that luteoloside treatment significantly inhibited GC‑cell proliferation, migration and invasion. The western blot results showed notable concentration‑dependent upregulation of p53 and p21 protein expression and downregulation of Bcl‑2 protein expression following luteoloside treatment. Overall, luteoloside inhibited the proliferation, migration and invasion of GC cells by activating the p53/p21 signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI

2 

Cao MM, Li H, Sun DQ, He SY, Lei L, Peng J and Chen WQ: Epidemiological trend analysis of gastric cancer in China from 2000 to 2019. Chin J Dig Surg. 20:102–109. 2021.

3 

Cao M and Chen W: Epidemiology of cancer in China and the current status of prevention and control. Chin J Clin Oncol. 46:145–149. 2019.

4 

Rawla P and Barsouk A: Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz Gastroenterol. 14:26–38. 2019.PubMed/NCBI

5 

Kobayashi J: Effect of diet and gut environment on the gastrointestinal formation of N-nitroso compounds: A review. Nitric Oxide. 73:66–73. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Ilson DH: Advances in the treatment of gastric cancer: 2019. Curr Opin Gastroenterol. 35:551–554. 2019. View Article : Google Scholar : PubMed/NCBI

7 

Li M, Wang MM, Guo XW, Wu CY, Li DR, Zhang X and Zhang PT: Different survival benefits of Chinese medicine for pancreatic cancer: How to choose? Chin J Integr Med. 24:178–184. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Jia W and Wang L: Using traditional Chinese medicine to treat hepatocellular carcinoma by targeting tumor immunity. Evid Based Complement Alternat Med. 2020:98434862020. View Article : Google Scholar : PubMed/NCBI

9 

Bouyahya A, Taha D, Benali T, Zengin G, El Omari N, El Hachlafi N, Khalid A, Abdalla AN, Ardianto C, Tan CS, et al: Natural sources, biological effects, and pharmacological properties of cynaroside. Biomed Pharmacother. 161:1143372023. View Article : Google Scholar : PubMed/NCBI

10 

Jiao GY, Li SK, Deng Y, Yin J, Chen WS, Chen JF and Zhang F: Review of pharmacological effects, metabolism and quality control of Eclipta prostrata L. and its chemical components. J Pharm Res. 40:673–677. 6832021.

11 

Gupta A, Kumar A, Kumar D, Nandan S, Shankar K, Varshney S, Rajan S, Srivastava A, Gupta S, Kanojiya S, et al: Ethyl acetate fraction of Eclipta alba: A potential phytopharmaceutical targeting adipocyte differentiation. Biomed Pharmacother. 96:572–583. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Yadav NK, Arya RK, Dev K, Sharma C, Hossain Z, Meena S, Arya KR, Gayen JR, Datta D and Singh RK: Alcoholic Extract of Eclipta alba shows in vitro antioxidant and anticancer activity without exhibiting toxicological effects. Oxid Med Cell Longev. 2017:90946412017. View Article : Google Scholar : PubMed/NCBI

13 

Ryu S, Shin JS, Jung JY, Cho YW, Kim SJ, Jang DS and Lee KT: Echinocystic acid isolated from Eclipta prostrata suppresses lipopolysaccharide-induced iNOS, TNF-α, and IL-6 expressions via NF-κB inactivation in RAW 264.7 macrophages. Planta Med. 79:1031–1037. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Timalsina D and Devkota HP: Eclipta prostrata (L.) L. (asteraceae): Ethnomedicinal uses, chemical constituents, and biological activities. Biomolecules. 11:17382021. View Article : Google Scholar : PubMed/NCBI

15 

Rehfeldt SCH, Silva J, Alves C, Pinteus S, Pedrosa R, Laufer S and Goettert MI: Neuroprotective effect of luteolin-7-O-glucoside against 6-OHDA-induced damage in undifferentiated and RA-differentiated SH-SY5Y cells. Int J Mol Sci. 23:29142022. View Article : Google Scholar : PubMed/NCBI

16 

Caporali S, De Stefano A, Calabrese C, Giovannelli A, Pieri M, Savini I, Tesauro M, Bernardini S, Minieri M and Terrinoni A: Anti-inflammatory and active biological properties of the plant-derived bioactive compounds luteolin and luteolin 7-glucoside. Nutrients. 14:11552022. View Article : Google Scholar : PubMed/NCBI

17 

Schonhofer C, Yi J, Sciorillo A, Andrae-Marobela K, Cochrane A, Harris M, Brumme ZL, Brockman MA, Mounzer K, Hart C, et al: Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency. Biochem Pharmacol. 186:1144622021. View Article : Google Scholar : PubMed/NCBI

18 

Ji J, Wang Z, Sun W, Li Z, Cai H, Zhao E and Cui H: Effects of cynaroside on cell proliferation, apoptosis, migration and invasion though the MET/AKT/mTOR axis in gastric cancer. Int J Mol Sci. 22:121252021. View Article : Google Scholar : PubMed/NCBI

19 

Velmurugan BK, Lin JT, Mahalakshmi B, Chuang YC, Lin CC, Lo YS, Hsieh MJ and Chen MK: Luteolin-7-O-glucoside inhibits oral cancer cell migration and invasion by regulating matrix metalloproteinase-2 expression and extracellular signal-regulated kinase pathway. Biomolecules. 10:5022020. View Article : Google Scholar : PubMed/NCBI

20 

Arora M: Cell culture media: A review. Mater Methods. 3:1752013. View Article : Google Scholar

21 

Rong L, Li Z, Leng X, Li H, Ma Y, Chen Y and Song F: Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway. Biomed Pharmacother. 122:1097262020. View Article : Google Scholar : PubMed/NCBI

22 

Ji H and Zhang X: RPL38 regulates the proliferation and apoptosis of gastric cancer via miR-374b-5p/VEGF signal pathway. Onco Targets Ther. 13:6131–6141. 2020. View Article : Google Scholar : PubMed/NCBI

23 

Pei J, Wei D and Jiang L: Effects of Yiqi huayu sanjie decoction on PI3K-AKT-mTOR signal pathway of gastric cancer cell line of SGC-7901. World Chin Med. 15:2686–2689. 26952020.

24 

Jeong S, Jo MJ, Yun HK, Kim DY, Kim BR, Kim JL, Park SH, Na YJ, Jeong YA, Kim BG, et al: Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death Dis. 10:8462019. View Article : Google Scholar : PubMed/NCBI

25 

Liang JR and Yang H: Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS. Biomed Pharmacother. 125:1095852020. View Article : Google Scholar : PubMed/NCBI

26 

Gao S, Tan H and Li D: Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis. J Cell Mol Med. 27:2661–2674. 2023. View Article : Google Scholar : PubMed/NCBI

27 

Mao Y and Jiang P: The crisscross between p53 and metabolism in cancer. Acta Biochim Biophys Sin (Shanghai). 55:914–922. 2023. View Article : Google Scholar : PubMed/NCBI

28 

Gu X, Wang Z, Gao J, Han D, Zhang L, Chen P, Luo G and Han B: SIRT1 suppresses p53-dependent apoptosis by modulation of p21 in osteoblast-like MC3T3-E1 cells exposed to fluoride. Toxicol In Vitro. 57:28–38. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Zhuang C, Zhao J, Zhang S and Shahid M: Escherichia coli infection mediates pyroptosis via activating p53-p21 pathway-regulated apoptosis and cell cycle arrest in bovine mammary epithelial cells. Microb Pathog. 184:1063382023. View Article : Google Scholar : PubMed/NCBI

30 

Kim EM, Jung CH, Kim J, Hwang SG, Park JK and Um HD: The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins. Cancer Res. 77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Nabavi SF, Braidy N, Gortzi O, Sobarzo-Sanchez E, Daglia M, Skalicka-Woźniak K and Nabavi SM: Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res Bull. 119:1–11. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Li Q, Tian Z, Wang M, Kou J, Wang C, Rong X, Li J, Xie X and Pang X: Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway. Int Immunopharmacol. 66:309–316. 2019. View Article : Google Scholar : PubMed/NCBI

33 

Park CM and Song YS: Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells. Nutr Res Pract. 7:423–429. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Lin J, Chen J, Zhang Z, Xu T, Shao Z, Wang X, Ding Y, Tian N, Jin H, Sheng S, et al: Luteoloside inhibits IL-1β-induced apoptosis and catabolism in nucleus pulposus cells and ameliorates intervertebral disk degeneration. Front Pharmacol. 10:8682019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lin X, Yang P, Li X, Xu Z, Wu H, Hu S, Yang X, Ding Y and Yu W: Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway. Oncol Lett 29: 76, 2025.
APA
Lin, X., Yang, P., Li, X., Xu, Z., Wu, H., Hu, S. ... Yu, W. (2025). Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway. Oncology Letters, 29, 76. https://doi.org/10.3892/ol.2024.14822
MLA
Lin, X., Yang, P., Li, X., Xu, Z., Wu, H., Hu, S., Yang, X., Ding, Y., Yu, W."Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway". Oncology Letters 29.2 (2025): 76.
Chicago
Lin, X., Yang, P., Li, X., Xu, Z., Wu, H., Hu, S., Yang, X., Ding, Y., Yu, W."Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway". Oncology Letters 29, no. 2 (2025): 76. https://doi.org/10.3892/ol.2024.14822
Copy and paste a formatted citation
x
Spandidos Publications style
Lin X, Yang P, Li X, Xu Z, Wu H, Hu S, Yang X, Ding Y and Yu W: Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway. Oncol Lett 29: 76, 2025.
APA
Lin, X., Yang, P., Li, X., Xu, Z., Wu, H., Hu, S. ... Yu, W. (2025). Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway. Oncology Letters, 29, 76. https://doi.org/10.3892/ol.2024.14822
MLA
Lin, X., Yang, P., Li, X., Xu, Z., Wu, H., Hu, S., Yang, X., Ding, Y., Yu, W."Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway". Oncology Letters 29.2 (2025): 76.
Chicago
Lin, X., Yang, P., Li, X., Xu, Z., Wu, H., Hu, S., Yang, X., Ding, Y., Yu, W."Network pharmacology‑based analysis and <em>in vitro</em> experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway". Oncology Letters 29, no. 2 (2025): 76. https://doi.org/10.3892/ol.2024.14822
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team